300246SZSE
🚨 Material Event

Announcement on Resolutions of the 13th Meeting of the 9th Board of Directors

Baolait Technology Co., Ltd.··2 pages

✨ AI Summary

The Board of Directors of Guangdong Baolight Medical Technology Co., Ltd. approved the termination of certain investment projects and the use of remaining funds for working capital. They also approved the re-appointment of auditors and the convening of the third extraordinary general meeting of shareholders.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Securities Code: 300246

Bond Code: 123065

Securities Abbreviation: Baolight

Bond Abbreviation: Baolight Convertible Bond

Announcement Number: 2026-051

Guangdong Baolight Medical Technology Co., Ltd.

Announcement on Resolutions of the 13th Meeting of the 9th Board of Directors

The Company and all members of the Board of Directors guarantee that the information disclosed is true, accurate, and complete, and that there are no false records, misleading statements, or major omissions.

Guangdong Baolight Medical Technology Co., Ltd. (hereinafter referred to as the "Company") held the 13th meeting of the 9th Board of Directors on August 4, 2026, using a combination of written voting and in-person meetings. The meeting notice was sent via email, telephone, and fax on August 1, 2026. The Company's Board of Directors has nine directors, all of whom participated in the voting. The Company's Board Secretary and other senior management personnel attended the meeting. This complies with the "Company Law" and the "Articles of Association."

The meeting was chaired by Mr. Yan Jinyuan, Chairman of the Board. The following proposals were voted on and approved:

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.